OR WAIT null SECS
April 26, 2019
Biocatalysts, a global biotechnology company, has announced it has been named as one of the winners of the Queen’s Awards for Enterprise in Innovation.
April 24, 2019
Expansion at GSK’s Hamilton, MT site is designed to boost vaccine production capacity.
April 17, 2019
AstraZeneca and MSD have announced the EC's approval of Lynparza (olaparib) as a monotherapy in the treatment of advanced or metastatic breast cancer.
April 12, 2019
Brexit has the potential to rumble on until Oct. 31, 2019 as the UK is granted a further six-month extension by European Union leaders.
Shareholders have approved the issuance of Bristol-Myers Squibb common stock for the pending $74-billion merger with Celgene.
April 09, 2019
With the spin-off, Alcon will operate as a standalone company, and Novartis will focus on its core innovative medicines.
March 21, 2019
Merck KGaA opened a collaborative bio/pharma development facility in Molsheim, France and announced an investment plan through 2025 for its Darmstadt, Germany headquarters.
March 18, 2019
Richard Francis will step down as CEO of Sandoz, effective March 31, 2019.
March 12, 2019
The acquisition of the site in Copenhagen, Denmark, will significantly expand Fujifilm’s capacity and capabilities.
March 02, 2019
Do patients get what they pay for when they demand cheaper drugs?